![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication November 23, 2004.
Revised January 27, 2005.
Accepted for publication January 31, 2005.
7-NICOTINIC ACETYLCHOLINE RECEPTOR-MEDIATED RESPONSES IN XENOPUS OOCYTES
The interaction between the effects of the endogenous cannabinoid receptor agonist anandamide and ethanol on the function of homomeric
7-nicotinic acetylcholine (nACh) receptors expressed in Xenopus oocytes were investigated using the two-electrode voltage-clamp technique. Anandamide and ethanol reversibly inhibited currents evoked with ACh (100 ìM) in a concentration-dependent manner. Coapplication of anandamide and ethanol caused a significantly greater inhibition of
7- nACh receptor function than anandamide or ethanol alone. The IC50 value of 238 ± 34 nM for anandamide inhibition decreased significantly to 104 ± 23 nM in the presence of 30 mM ethanol. The inhibition of
7-mediated currents by coapplication of anandamide and ethanol was not altered by phenylmethylsulfonyl fluoride, an inhibitor of anandamide hydrolyzing enzyme, or AM404, an anandamide-transport inhibitor. Analysis of oocytes by matrix-assisted laser desorption/ionization technique indicated that ethanol treatment did not alter the lipid profile of oocytes and there is negligible, if any, anandamide present in these cells. Results of studies with chimeric
7-nACh-5-HT3 receptors comprised of the amino-terminal domain of the
7-nACh receptor and the transmembrane and carboxyl-terminal domains of 5-HT3 receptors suggest that while ethanol inhibition of the
7-nAChR is likely to involve the N-terminal region of the receptor, the site of action for anandamide is located in the transmembrane and carboxyl-terminal domains of the receptors. These data indicate that endocannabinoids and ethanol potentiate each other's inhibitory effects on
7-nACh receptor function through distinct regions of the receptor.
Key words:
anandamide, drug abuse, endocannabinoid, ethanol, ligand-gated receptor, nicotinic receptor
This article has been cited by other articles:
![]() |
U. Baranowska, M. Gothert, R. Rudz, and B. Malinowska Methanandamide Allosterically Inhibits in Vivo the Function of Peripheral Nicotinic Acetylcholine Receptors Containing the {alpha}7-Subunit J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 912 - 919. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Spivak, C. R. Lupica, and M. Oz The Endocannabinoid Anandamide Inhibits the Function of {alpha}4beta2 Nicotinic Acetylcholine Receptors Mol. Pharmacol., October 1, 2007; 72(4): 1024 - 1032. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hejazi, C. Zhou, M. Oz, H. Sun, J. H. Ye, and L. Zhang {Delta}9-Tetrahydrocannabinol and Endogenous Cannabinoid Anandamide Directly Potentiate the Function of Glycine Receptors Mol. Pharmacol., March 1, 2006; 69(3): 991 - 997. [Abstract] [Full Text] [PDF] |
||||